AlphaCrest Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$25.2M |
| 2 |
Texas Instruments
TXN
|
+$20.4M |
| 3 |
Medtronic
MDT
|
+$17.8M |
| 4 |
Analog Devices
ADI
|
+$17.3M |
| 5 |
Yum China
YUMC
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$13.2M |
| 2 |
CERN
Cerner Corp
CERN
|
+$10.4M |
| 3 |
Abbott
ABT
|
+$7.92M |
| 4 |
Walt Disney
DIS
|
+$7.58M |
| 5 |
Crown Castle
CCI
|
+$7.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 13.23% |
| 5 | Consumer Discretionary | 11.11% |
Similar funds
AlphaCrest Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, AlphaCrest Capital Management held 1,493 positions worth $2.69B, up 39% from $1.93B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
AlphaCrest Capital Management deployed $669M of net new capital in Q4 2021, opening 266 new positions and adding to 636 existing holdings. Its largest new stake was Yum China: 269,184 shares worth $13.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $13.2M trimmed.
- AlphaCrest Capital Management's largest Q4 2021 buy was Yum China: 269,184 shares worth $13.4M.
- AlphaCrest Capital Management added most to Oracle in Q4 2021, an estimated $25.2M increase.
- AlphaCrest Capital Management's biggest Q4 2021 reduction was Union Pacific, cutting an estimated $13.2M.
- AlphaCrest Capital Management fully exited Cerner Corp in Q4 2021, selling an estimated $10.4M.
- AlphaCrest Capital Management's ten largest holdings make up 7.2% of its $2.69B portfolio in Q4 2021.
- AlphaCrest Capital Management opened 266 new positions and closed 143 in Q4 2021.
- AlphaCrest Capital Management's portfolio value rose 39% quarter-over-quarter to $2.69B.
Based on AlphaCrest Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.